AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neurophysiological and Behavioral Study of the Cognitive Deficits Associated With Cerebral Small Vessel Disease in the SHIVA Cohort. SHIVA-CogNeurophys

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Bordeaux
💬

In plain words

What the trial is, and whether it could suit you

Cerebral small vessel disease (cSVD) is characterized by an alteration of the structure and function of small penetrating brain arteries. Highly prevalent in older individuals from the general population, it represents a leading cause of stroke and a major contributor to cognitive decline and risk of dementia. Better detection and management of covert cSVD would have a major impact on preventing disability and costs related to stroke, cognitive impairment and dementia. The aim of the present study is to identify novel electroencephalographic (EEG) biomarkers of the cognitive deficits associated with cSVD, and how these biomarkers and cognitive performance are affected by personalized cognitive training or transcranial alternating current stimulation (tACS), a non-invasvie brain stimulation technique.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients included or previously included in the SHIVA cohort * Basic computer skills (ability to open a browser, use a mouse and keyboard) * Access to a personal computer with an internet connection * Independent in Activities of Daily Living (ADL) with a score ≥ 5/6, and in Instrumental Activities of Daily Living (IADL) with a score ≥ 4/8 * Informed and written consent signed by the participant and the investigating physician for this study Exclusion Criteria: * Motor impairments preventing the use of a keyboard and mouse (e.g., motor issues related to severe hand osteoarthritis) * Depressive symptoms indicated by a score of 2 to 4 on the mini Geriatric Depression Scale (mini GDS), which includes 4 items * Age-related macular degeneration (AMD) * Untreated glaucoma * Untreated psychiatric conditions that interfere with cognitive assessments * Diagnosed attention deficit disorder with or without hyperactivity or patients who could not complete all cognitive tests required in the SHIVA cohort * Systemic diseases that cause cognitive changes, such as obesity and metabolic disorders * History of epilepsy or seizures * Scalp sensitivity or skin lesions (dermatitis, wounds, etc.) Contraindications for the use of electrical stimulation: * Surgical clips, metal sutures, staples, stents * Osteosynthesis material in the head or neck * Pacemaker * Implanted hearing aid * Ocular foreign bodies, shrapnel, bullets * Metalworker * Pacemaker or neurostimulator * Heart valve or endovascular material * Ventricular shunt valve * Recent exposure (\< 6 months) to brain stimulation (tDCS, TMS, etc.) * Ongoing participation in a clinical trial or cognitive training program
💊

What it tests

  • Home-based cognitive training
📍

Where

1 site
CHU de Bordeaux, Hôpital Pellegrin, Unité Neurovasculaire
Bordeaux, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy